Patheon Can't Duck JV Partner's Suit Over $255M Acquisition

Law360, New York (February 25, 2013, 8:04 PM EST) -- A Florida federal judge said Friday that Procaps SA can contest joint venture partner Patheon Inc.'s $255 million acquisition of a pharmaceutical company, shooting down Patheon's argument that Procaps actually stood to benefit from the deal's alleged anti-competitive impacts.

U.S. District Judge Donald L. Graham ruled that Procaps — which previously agreed to collaborate with Patheon on development of a softgel capsule service for pharmaceutical products — had standing to bring its complaint under antitrust laws, according to an order. Procaps alleged in the suit that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.